Details for Patent: RE44048

✉ Email this page to a colleague

Summary for Patent: RE44048

Title:	4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-YL]benzenesulfonami- de for the treatment of inflammation or an inflammation-associated disorder
Abstract:	.[.A class of pyrazolyl benzenesulfonamide compounds is described for use in treating inflammation and inflammation-related disorders. Compounds of particular interest are defined by Formula II: ##STR00001## or a pharmaceutically-acceptable salt thereof..]. .Iadd.A method of treating inflammation or an inflammation-associated disorder in a subject by administering a therapeutically-effective dose of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonam- ide, or a pharmaceutically-acceptable salt thereof, to the subject..Iaddend.
Inventor(s):	Talley; John J. (St. Louis, MO), Bertenshaw; Stephen R. (Cheshire, CT), Miyashiro; Julie M. (Morton Grove, IL)
Assignee:	G.D. Searle LLC (New York, NY)
Application Number:	12/205,319
Patent Claim Types: see list of patent claims	Use;

Drugs Protected by US Patent RE44048

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: RE44048

PCT Information
PCT Filed	November 14, 1994	PCT Application Number:	PCT/US94/12720
PCT Publication Date:	June 08, 1995	PCT Publication Number:	WO95/15316

International Family Members for US Patent RE44048

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	0731795	⤷ Sign Up	CA 2009 00005	Denmark	⤷ Sign Up
European Patent Office	0731795	⤷ Sign Up	91538	Luxembourg	⤷ Sign Up
European Patent Office	0731795	⤷ Sign Up	300380	Netherlands	⤷ Sign Up
European Patent Office	0731795	⤷ Sign Up	SPC004/2009	Ireland	⤷ Sign Up
European Patent Office	0731795	⤷ Sign Up	09C0007	France	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.